Simple Summary Esophageal cancer (EC) is the eighth most frequent cancer worldwide,
with a poor prognosis. Current imaging modalities for staging and follow-up mainly include …

Esophageal cancer is the sixth most common cause of cancer related mortality worldwide.
Advances in treatment have translated into steadily improving survival rates. Accurate …

Currently, the use of magnetic resonance imaging (MRI) in patients with esophageal
carcinoma is limited. However, the quality of MRI for esophageal carcinoma continues to …

Objectives To outline the current role and future potential of magnetic resonance imaging
(MRI) in the management of oesophageal cancer regarding T-staging, N-staging, tumour …

Background Although CT, endoscopic US, and PET are critical in determining the
appropriate management of esophageal carcinoma (squamous cell carcinoma and …

Over the past few decades, the survival of esophageal cancer patients has improved owing
to early detection and advances in multimodality treatment strategies. Imaging plays an …

Objective: To compare the diagnostic performance of MR and diffusion-weighted imaging
(DWI), multidetector CT, endoscopic ultrasonography (EUS) and 18F-FDG (fluorine-18 …

Esophageal cancer is a relatively uncommon gastrointestinal malignancy but carries a poor
prognosis unless it is of early stage and can be surgically resected for cure. Resectability is …

Background: Positron emission tomography and computed tomography (PET-CT) is
established in the staging of esophageal cancer. In this study, an MRI protocol was …

CT and EUS are complimentary modalitiesthat allow accurate esophageal cancer staging.
To prevent unnecessary surgical interventions, patients should undergo selective imaging …